Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Oxidative Injury
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 33400 |
(±)10- |
90780-50-0 | >98% |
|
8.433816758747 | -10-hdohe | 10-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)10-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10008043 |
10- |
88127-53-1 | >98% |
|
2006-08-01 | 18.803176795580 | 10-nitrooleate | 10-nitro-9-trans-Octadecenoic Acid | oleic acids nitration 9-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes | ||
| 33450 |
(±)11- |
87018-59-5 | >98% |
|
7.419307090239 | -11-hdohe | 11-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)11-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 37500 |
(±)11- |
5598-37-8 | >98% |
|
0.199410681399 | -11-hede | racemic hydroxy fatty acids autoxidation (+/-)11-HEDEs (+/-)-HEDEs (+/-)HEDEs | ||||
| 32500 |
(±)11- |
99217-78-4 | >98% |
|
7.703270718232 | -11-hepe | racemic hydroxy acids EPA autoxidation (+/-)11-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs | ||||
| 34500 |
(±)11- |
73804-65-6 | >98% |
|
26.709571823204 | -11-hete | racemic hydroxy acids autoxidation (+/-)11-HETEs fatty (+/-)-HETEs (+/-)HETEs | ||||
| 32540 |
(±)12- |
81187-21-5 | >98% |
|
14.612472375690 | -12-hepe | racemic monohydroxy acids EPA autoxidation (+/-)12-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs polyunsaturated | ||||
| 34550 |
(±)12- |
71030-37-0 | >98% |
|
42.237071823204 | -12-hete | racemic hydroxy acids autoxidation (+/-)12-HETEs fatty (+/-)-HETEs (+/-)HETEs | ||||
| 33500 |
(±)13- |
90780-53-3 | >98% |
|
11.103225138121 | -13-hdohe | 13-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)13-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 38600 |
(±)13- |
73804-64-5 | >98% |
|
17.100681399632 | -13-hode | atherosclerosis LDL oxidized lipids racemic autoxidation (+/-)13-HODEs hydroxy fatty acids (+/-)-HODEs (+/-)HODEs | ||||
| 38601 |
(±)13- |
167354-91-8 | >98% |
|
2.652044198895 | -13-hode-cholesteryl-ester | atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids (+/-)13-HODEs esters racemic | ||||
| 38606 |
13(R)- |
- | >98% |
|
0.495395948434 | 13-r-hode-cholesteryl-ester | atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13R-HODEs esters | ||||
| 38611 |
13(S)- |
- | >98% |
|
6.375096685082 | 13-s-hode-cholesteryl-ester | atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13S-HODEs esters 13(S)HODEs 13(S)-HODEs | ||||
| 10006998 |
(±)- |
- | >98% |
|
✓ | 2005-07-13 | 18.504986187845 | -14-15-dihete | (±)14,15-Dihydroxy-Eicosa-5,8,11,17-Tetraenoic Acid; 116477-54-4 | epoxygenases metabolites EPA eicosapentaenoic acids epoxidations hydroxylations w-3 .omega.-3 fatty acids marine organisms incubated rats livers microsomes colitis homogenates cytochromes P450-catlyzed epoxidations w-6 .omega.-6 double bonds conversion vicinal diols epoxides hydrolases excreted excretion humans ingesting fish oils supplements | |
| 33550 |
(±)14- |
87042-40-8 | >98% |
|
14.898119244936 | -14-hdohe | 14-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)14-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 37700 |
(±)15- |
77159-57-0 | >98% |
|
0.199410681399 | -15-hede | hydroxy fatty acids autoxidation racemic (+/-)15-HEDEs (+/-)-HEDEs (+/-)HEDEs | ||||
| 32700 |
(±)15- |
88852-33-9 | >98% |
|
8.391270718232 | -15-hepe | racemic hydroxy acids EPA autoxidation (+/-)15-HEPEs eicosapentaenoic (+/-)-HEPEs fatty (+/-)HEPEs | ||||
| 34700 |
(±)15- |
73836-87-0 | >98% |
|
24.630041436464 | -15-hete | racemic hydroxy acids autoxidation (+/-)15-HETEs fatty (+/-)-HETEs 15HETE | ||||
| 33600 |
(±)16- |
90780-51-1 | >98% |
|
7.419307090239 | -16-hdohe | 16-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)16-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10006999 |
(±)- |
- | >98% |
|
✓ | 2005-07-13 | 16.902440147329 | -17-18-dihete | (±)17,18-dihydroxy-eicosa-5,8,11,14-Tetraenoic Acid | EPAs eicosapentaenoic acids epoxidations hydroxylations epoxygenases metabolites w-3 .omega.-3 fatty marine organisms metabolites produced incubated rat tissues homogenates cynomolgus monkey seminal vesicles cytochrome P450-catalyzed double bond conversion vicinal diols epoxides hydrolases metabolized Gaeumannomyces graminis 116477-53-3 | |
| 33650 |
(±)17- |
90780-52-2 | >98% |
|
12.725023374415 | -17-hdohe | 17-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)17-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 32840 |
(±)18- |
141110-17-0 | ≥97% |
|
12.662209944751 | -18-hepe | racemic hydroxy acids EPA autoxidation (+/-)18-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs | ||||
| 33750 |
(±)20- |
90906-41-5 | >98% |
|
12.104127532228 | -20-hdohe | 20-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)20-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 16290 |
2,3- |
221664-05-7 | >98% |
|
52.645165745856 | 2-3-dinor-8-iso-prostaglandin-f2 | 2,3-dinor-iPF2α-III; 2,3-dinor-8-iso PGF2α | 8-isoprostanes vasoconstriction 2,3-dinor-8-epi-PGF2.alpha. metabolites .beta.-oxidation beta-oxidation b-oxidation 2,3-dinor-8-epi-PGF2alpha 2,3-dinor-8-iso-PGF2.alpha. 2,3-dinor-8-iso-PGF2alpha prostaglandins | |||
| 10004185 |
3,4',5- |
94709-12-3 | >95% |
|
✓ | 2004-07-21 | 20.571178637200 | 3-4-5-trismethoxybenzophenone | antimitotics antimitosis resveratrol analogs phenolic antioxidants antiproliferative antiproliferatory inhibits inhibition inhibitors cell growth | ||
| 33200 |
(±)4- |
90906-40-4 | >98% |
|
13.391777564256 | -4-hdohe | 4-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)4-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10004413 |
4- |
7439-43-2 | >95% |
|
2005-05-25 | 38.345569060773 | 4-hydroperoxy-2-nonenal | 4-HpNE | free radicals peroxidation lipids oxidized w-6 .omega.-6 omega-6 PUFAs polyunsaturated fatty acids linoleics arachidonics oxidative stress cytotoxicity growth inhibiting activity genotoxicity chemotactic 4-HNE 4-hydroxy nonenals 4-OH-nonenal 4-hydroxynonenal hydroperoxides injury | ||
| 32060 |
4- |
160708-91-8 | >98% |
|
151.648066298342 | 4-hydroxy-hexenal | 4-HHE | ROS alkenal aldehydes radicals peroxidation lipids autoxidation reactive oxygen species free 4-OH-hexenal | |||
| 32100 |
4- |
75899-68-2 | >98% |
|
146.930077348066 | 4-hydroxy-nonenal | 4-HNE | ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal | |||
| 13265 |
4- |
1011268-23-7 | ≥98% |
|
✓ | 2010-06-16 | 0E-12 | 4-hydroxy-nonenal-alkyne | Click Tag™ 4-HNE alkyne | lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT | |
| 332101 |
4- |
- | ≥99% deuterated product |
|
2004-01-28 | 50.109990791896 | 4-hydroxy-nonenal-d3 | 4-HNE-d3 | ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal deuterium deuterateds | ||
| 32110 |
4- |
146764-24-1 | >98% |
|
2.168508287293 | 4-hydroxy-nonenal-mercapturic-acid | 4-HNE 4HNE b-cleavage .beta.-cleavage beta-cleavage urine enterohepatic circulation conjugates acids 4-hydroxynonenal 4-OH-nonenal | ||||
| 9000348 |
4- |
- | ≥99% deuterated product |
|
2008-12-03 | 28.741834254143 | 4-hydroxy-nonenal-mercapturic-acid-d3 | 4-HNE 4HNE b-cleavage .beta.-cleavage beta-cleavage urine enterohepatic circulation conjugates acids 4-hydroxynonenal 4-OH-nonenal deuterium deuterateds | |||
| 10185 |
4- |
103560-62-9 | >98% |
|
2004-01-21 | 59.851837016574 | 4-oxo-2-nonenal | 4-ONE | ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species | ||
| 10004174 |
4- |
- | ≥99% deuterated product |
|
2004-03-10 | 34.416077348066 | 4-oxo-2-nonenal-d3 | 4-ONE-d3 | ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds | ||
| 32200 |
(±)5- |
83952-40-3 | >98% |
|
17.981063535911 | -5-hepe | racemic hydroxy acids fatty EPA autoxidation (+/-)5-HEPEs eicosapentanoic (+/-)-HEPEs (+/-)HEPEs | ||||
| 34210 |
(±)5- |
73307-52-5 | >98% |
|
9.748287292817 | -5-hete | racemic hydroxy acids autoxidation (+/-)5-HETEs fatty arachidonic AA (+/-)-HETEs (+/-)HETEs | ||||
| 34215 |
(±)5- |
73279-37-5 | >98% |
|
14.006097438473 | -5-hete-lactone | racemic hydroxy acids lactones autoxidation (+/-)5-HETEs fatty (+/-)-HETEs (+/-)HETEs inhibitors inhibits 5-LOs 5-lipoxygenases | ||||
| 34220 |
(±)5- |
73279-38-6 | >98% |
|
8.081767955801 | -5-hete-methyl-ester | racemic hydroxy acids autoxidation (+/-)5-HETEs fatty (+/-)-HETEs esters AA (+/-)HETEs arachidonic (+/-)5-HETE-OMe | ||||
| 16300 |
5- |
180469-63-0 | >95% |
|
2006-02-06 | 29.950497237569 | 5-ipf2-vi | iPF2α-I | marker oxidative injury 8-isoprostanes prostaglandins PGs free-radical lipids peroxidations ipf2a arachidonic acids polyunsaturated fatty stereo- regioisomeric oxidative stress Type VI internal lactones facilitates extraction purification pgf2a | ||
| 10006654 |
5- |
- | ≥99% deuterated product |
|
2005-03-17 | 100.685147329650 | 5-ipf2-vi-d11 | isoprostanes peroxidation oxidative injury deuterateds deuteriums isotopes 8,12-isoprostanes iPF2alpha-VI-d11 prostaglandins iPF2a-VI-d11 urine peroxidative damage enantiomers stress | |||
| 10007601 |
5α- |
13027-33-3 | >98% |
|
2005-11-11 | 225.631675874769 | 5-hydroxy-6-keto-cholesterol | 6-Oxo-3,5-diol; Cholestane-6-oxo-3β,5α-diol | atherosclerosis cholesterols ozonolysis cytotoxicity metabolites ozone-oxidized lipids surfactants lungs epithelials lining fluids exposures cells bronchalveoalar lavaged homogenates inhibits inhibitors synthesis bronchial cytotoxicity toxic oxysterols hydroxycholesterol | ||
| 10009856 |
7- |
- | 2008-10-29 | 14.545303867403 | 7-aad-cell-viability-assay-kit | 7-Amino Actinomycin D Cell Viability Kit | kits 7AAD measurement cells fixation blocking cytoxicity effects environmental toxins drug fluorescence fluorescent cell-based assays cell based assay cba | ||||
| 33300 |
(±)7- |
90780-55-5 | >98% |
|
12.490425874770 | -7-hdohe | 7-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)7-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 10312 |
8,12- |
- | 98% |
|
✓ | 2009-08-07 | 7.755184162062 | 8-12-iso-ipf2-vi-1-5-lactone | lactone IPF2α -I iPF2α-VI F2-iP urine lipid peroxidation plasma biomarker oxidative stress 214894-81-2 214894-83-4 | ||
| 10006878 |
8,12- |
- | >99% deuterated product |
|
2005-09-01 | 18.056574585636 | 8-12-iso-ipf2-vi-d11 | 8,12-epi-iPF2α-VI-d11 | GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience | ||
| 33350 |
(±)8- |
90780-54-4 | >98% |
|
7.800522559853 | -8-hdohe | 8-hydroxy Docosahexaenoic Acid | racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)8-HDoHEs (+/-)HDoHEs neurochemistry | |||
| 32340 |
(±)8- |
- | >98% |
|
8.057409453652 | -8-hepe | racemic hydroxy acids EPA autoxidation (+/-)8-HEPEs eicosapentanoic (+/-)-HEPEs fatty (+/-)HEPEs | ||||
| 34340 |
(±)8- |
79495-84-4 | >98% |
|
6.353804262036 | -8-hete | racemic hydroxy acids autoxidation (+/-)8-HETEs (+/-)-HETEs (+/-)HETEs | ||||
| 89320 |
8- |
- | >98% |
|
✓ | 18.890870165746 | 8-hydroxy-2-deoxy-guanosine | 8-OH-dG | oxidative injury stress DNA hydroxyl radicals peroxynitrite | ||
| 589320 |
8- |
- |
|
2008-05-21 | 619.851366147664 | 8-hydroxy-2-deoxy-guanosine-eia-kit | 8-OH-dG ELISA Kit; DNA Damage EIA Kit | oxidative injury stress aging cancers diabetes hypertension hydroxyl radicals peroxynitrite plasmas cells lysates tissues urine creatinine LC-MS liquid DNA damage kits EIAs chormatography mass spectrometry kits enzyme immunoassays elisas 8-OH-2-d 8OH2d 8 oxo deoxyguanine deoxyguanosine hydroxy ohdg 2 EIA/ELISA assays | |||
| 89290 |
8- |
- | >90% |
|
9.526869244935 | 8-hydroxy-guanine | 8-Oxoguanine | oxidative injury DNA RNA peroxynitrite radicals 5614-64-2 8-hydroxyguanine | |||
| 89300 |
8- |
- | >98% |
|
11.989834254143 | 8-hydroxy-guanosine | oxidative injury RNA stress damage 7,8-dihydro-8-oxo-guanosine markers inhibitors growth 3868-31-3 | ||||
| 16380 |
8- |
191919-02-5 | >98% |
|
43.677403314917 | 8-iso-13-14-dihydro-15-keto-prostaglandin-f2 | 8-iso-13,14-dihydro-15-keto PGF2α | 8-isoprostanes lipid peroxidation metabolites prostaglandins 8-epi-13,14-dihydro-15-keto-PGF2.alpha. 8-epi-13,14-dihydro-15-keto-PGF2alpha 8-iso-13,14-dihydro-15-keto-PGF2.alpha. 8-iso-13,14-dihydro-15-keto-PGF2alpha | |||
| 16390 |
8- |
- | >95% |
|
3.141933701657 | 8-iso-15-keto-prostaglandin-f2 | 8-iso-15-keto PGF2α; 8-epi-15-keto PGF2α | 8-isoprostanes metabolites prostaglandins 8-epi-15-keto-PGF2.alpha. 8-epi-15-keto-PGF2alpha 8-iso-15-keto-PGF2.alpha. 8-iso-15-keto-PGF2alpha | |||
| 10008539 |
8- |
- | >95% |
|
2006-06-21 | 1.581510128913 | 8-iso-15-keto-prostaglandin-f2 | prostaglandins PGF2a PGF2.alpha. 15-hydroxy PGDH isomers free radicals peroxidation arachidonic acids contractions umbilical veins artery human canine porcine pulmonary isoprostanes metabolites | |||
| 16395 |
8- |
214748-65-9 | >98% |
|
39.136527229676 | 8-iso-15-r-prostaglandin-f2 | 8-iso-15-epi PGF2α | 8-isoprostanes prostaglandins 8-epi-15R-PGF2.alpha. 8-epi-15R-PGF2alpha 8-iso-15R-PGF2.alpha. 8-iso-15R-PGF2alpha 8-epi-15(R)-PGF2.alpha. 8-epi-15(R)-PGF2alpha 8-iso-15(R)-PGF2.alpha. 8-iso-15(R)-PGF2alpha | |||
| 10009278 |
8- |
53319-30-5 | >97% |
|
2007-07-12 | 2.711887661141 | 8-iso-16-cyclohexyl-tetranor-prostaglandin-e2 | 8-iso-16-cyclohexyl-tetranor PGE2 | 8-iso PGE2 isoprostanes polyunsaturated fatty acids lipids peroxidation analogs PGs PUFAs | ||
| 10035 |
8- |
211186-29-7 | >97% |
|
61.223591160221 | 8-iso-prostaglandin-a1 | 8-iso PGA1; 8-epi PGA1 | 8-iso-pga1 8-epi-pga1 8-isoprostanes prostaglandins prostanoids | |||
| 10235 |
8- |
- | >98% |
|
2006-08-22 | 11.668784530386 | 8-iso-prostaglandin-a2 | prostaglandins vasodilation 8-iso-pga2 8-epi-pga2 8-isoprostanes prostanoids oxidative stress peroxidation dehydration rat liver | |||
| 13360 |
8- |
21003-46-3 | >98% |
|
94.936187845304 | 8-iso-prostaglandin-e1 | Ovinonic acid; 8-iso PGE1; 8-epi PGE1 | 8-iso-PGE1 8-epi-PGE1 8-isoprostanes vasoconstriction prostaglandins | |||
| 14350 |
8- |
27415-25-4 | >99% |
|
✓ | 16.221823204419 | 8-iso-prostaglandin-e2 | 8-iso PGE2; 8-epi PGE2 | 8-isoprostanes 8-epi-PGE2 8-iso-PGE2 renal vasoconstriction prostaglandins | ||
| 14352 |
8- |
330589-21-4 | >98% |
|
81.096353591160 | 8-iso-prostaglandin-e2-isopropyl-ester | 8-iso PGE2 isopropyl ester | 8-isoprostanes 8-epi-PGE2 8-iso-PGE2 esters prostaglandins vasoconstriction renal | |||
| 15350 |
8- |
26771-96-0 | >99% |
|
10.369152854512 | 8-iso-prostaglandin-f1 | 8-epi PGF1α | 8-isoprostanes 8-epi-PGF1.alpha. 8-epi-PGF1alpha 8-iso-PGF1.alpha. 8-iso-PGF1alpha prostaglandins | |||
| 15370 |
8- |
- | >99% |
|
3.994175217048 | 8-iso-prostaglandin-f1 | 8-iso PGF1β; 8-epi-9β-PGF1α | 8-isoprostanes 8-epi-PGF1beta 8-epi-PGF1.beta. 8-iso-PGF1beta 8-iso-PGF1.beta. prostaglandins 8-iso-9.beta.-PGF1.alpha. 8-iso-9beta-PGF1alpha 8-iso-9b-PGF1alpha | |||
| 16350 |
8- |
27415-26-5 | >99% |
|
163.467300024021 | 8-iso-prostaglandin-f2 | iPF2α-III; 8-epi PGF2α; 8-Isoprostane; 15-F2t-isoprostane | 8-isoprostanes vasoconstriction 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins | |||
| 316350 |
8- |
211105-40-7 | ≥99% deuterated product |
|
89.057449355433 | 8-iso-prostaglandin-f2-d4 | 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 | GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 | |||
| 10005764 |
8- |
- | >98% |
|
2004-09-24 | 34.881767955801 | 8-iso-prostaglandin-f2-ethanolamide | 8-Isoprostane Ethanolamide; 8-epi PGF2α Ethanolamide; 8-iso PGF2α Ethanolamide; iPF2α-III Ethanolamide | ethanolamides prostaglandins anandamides AEA COX-2 cox2 cyclooxygenases synthases isoprostanes 8-epi-PGF2alpha 8-iso-PGF2alpha arachidonoyl prostamides congeners decomposition standards non-enzymatic iPF2a-III PGHS2 PGHS-2 ethanolamines 714966-38-8 | ||
| 16370 |
8- |
177020-26-7 | >98% |
|
29.633101815311 | 8-iso-prostaglandin-f2 | 8-iso-9β-PGF2α; 8-iso PGF2β; 8-epi PGF2β | 8-isoprostanes 8-epi-PGF2beta 8-epi-PGF2.beta. 8-iso-PGF2beta 8-iso-PGF2.beta. prostaglandins 8-iso-9b-PGF2alpha 8-iso-9beta-PGF2alpha 8-iso-9.beta.-PGF2.alpha. 8-epi-9b-PGF2alpha 8-epi-9beta-PGF2alpha 8-epi-9.beta.PGF2.alpha. | |||
| 16992 |
8- |
7045-31-0 | >98% |
|
4.535469613259 | 8-iso-prostaglandin-f3 | 8-iso PGF3α; 8-epi PGF3α | 8-isoprostanes 8-epi-PGF3.alpha. 8-epi-PGF3alpha 8-iso-PGF3.alpha. 8-iso-PGF3alpha omega-3 prostaglandins .omega.-3 w-3 | |||
| 10010366 |
8- |
- | 2009-04-02 | 301.696919889502 | 8-isoprostane-affinity-column | 8-epi Prostaglandin F2α; 8-iso Prostaglandin F2α | oxidative injury stress reactive oxygen species ROS 8-epi-PGF2alpha 8-epi-PGF2.alpha. 8-iso-PGF2alpha 8-iso-PGF2.alpha. samples purifications columns prostaglandins purify eias enzyme immunoassays reagents 8-isoprostanes peroxidation free radicals antibodies | ||||
| 10368 |
8- |
- | 2009-04-07 | 278.710000000000 | 8-isoprostane-affinity-purification-kit-20-ml | 8-iso Prostaglandin F2α Affinity Purification Kit | 516358 immunoassays samples 8-iso PGF2a purified | ||||
| 10367 |
8- |
- | 2009-04-06 | 272.061892265193 | 8-isoprostane-affinity-purification-kit-4-ml | 8-iso Prostaglandin F2α Affinity Purification Kit; 8-epi Prostaglandin F2α Affinity Purification Kit; iPF2α-III Affinity Purification Kit | 10009944 immunoassays samples 8-iso PGF2a purified | ||||
| 10010365 |
8- |
- | 2009-03-27 | 286.294074585635 | 8-isoprostane-affinity-sorbent | 8-iso Prostaglandin F2α; 8-epi Prostaglandin F2α | oxidative injury stress reactive oxygen species ROS peroxidation free radicals 8-Isoprostanes samples purifications matrix sorbents 8-iso-pgf2alpha 8-epi-pgf2alpha 8-iso-pgf2.alpha. 8-epi-pgf2.alpha. prostaglandins eias enzyme immunoassays reagents purify resins antibodies | ||||
| 516351 |
8- |
- |
|
962.085051302288 | 8-isoprostane-eia-kit | iPF2α-III EIA Kit; 8-epi Prostaglandin F2α EIA Kit; 8-iso Prostaglandin F2α EIA Kit; 8-Isoprostane ELISA Kit | oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays | ||||
| 516351.1 |
8- |
- |
|
159.162558436039 | 8-isoprostane-eia-kit-solid-plate | 8-iso Prostaglandin F2α EIA Kit (Solid Plate); 8-Isoprostane ELISA Kit (Solid Plate) | reactive oxygen species oxidative injury stress 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays | ||||
| 516360 |
8- |
- |
|
2009-10-26 | 190.972742531549 | 8-isoprostane-express-eia-kit | 8-epi Prostaglandin F2α Express EIA Kit; iPF2α-III Express EIA Kit; 8-Isoprostane Express ELISA Kit; 8-iso Prostaglandin F2α Express EIA Kit | oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs | |||
| 516361 |
8- |
- |
|
2009-10-26 | 158.175725380169 | 8-isoprostane-express-eia-kit-solid-plate | oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs | ||||
| 53400 |
(±)9,10- |
263399-34-4 | >98% |
|
31.167090239410 | -9-10-dihome | Leukotoxin diol; (+/-)9(10)-dihydroxy-octadec-12-enoic Acid | epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 | |||
| 10009993 |
(±)9,10- |
- | ≥99% deuterated product |
|
2007-06-01 | 23.367071823204 | -9-10-dihome-d4 | epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 deuterated duteriums | |||
| 32400 |
(±)9- |
- | >98% |
|
6.161767955801 | -9-hepe | racemic hydroxy acids EPA autoxidation (+/-)9-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs | ||||
| 34400 |
(±)9- |
79495-85-5 | >98% |
|
4.427486187845 | -9-hete | racemic hydroxy acids autoxidation (+/-)9-HETEs fatty (+/-)-HETEs (+/-)HETEs | ||||
| 38400 |
(±)9- |
98524-19-7 | >98% |
|
10.996574585635 | -9-hode | racemic hydroxy fatty acids autoxidation (+/-)9-HODEs (+/-)HODEs (+/-)-HODEs oxidized | ||||
| 38401 |
(±)9- |
33783-76-5 | >98% |
|
3.593793738489 | -9-hode-cholesteryl-ester | atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters (+/-)9-HODEs (+/-)-HODEs (+/-)HODEs racemic | ||||
| 10008042 |
9- |
875685-44-2 | >98% |
|
2006-08-11 | 20.515718232044 | 9-nitrooleate | 9-nitro-9-trans-Octadecenoic Acid | oleic acids nitration 10-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes | ||
| 38406 |
9(R)- |
- | >98% |
|
0.513720073664 | 9-r-hode-cholesteryl-ester | atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters 9R-HODEs 9-HODEs 9(R)-HODEs 9(R)HODEs | ||||
| 38411 |
9(S)- |
- | >98% |
|
7.385013812154 | 9-s-hode-cholesteryl-ester | atherosclerosis LDL oxidized lipids hydroxy fatty acids 9-HODEs esters 9S-HODEs 9(S)-HODEs 9(S)HODEs | ||||
| 82235 | AAPH | 2997-92-4 | >98% |
|
23.526132596685 | aaph | free radicals generators generation lipid peroxidation compounds azo oxidative injury | ||||
| 10007686 | Acetyl Podocarpic Acid Anhydride Exclusive | 344327-48-6 | >98% |
|
✓ | 2007-07-11 | 95.170580110497 | acetyl-podocarpic-acid-anhydride | APD | receptors ABC1 ABCA1 oxysterol cholesterol LXRalpha LXR.alpha. LXRbeta LXR.beta. 7.alpha.-hydroxylase RXR retinoid agonists nuclear receptors atherosclerosis acetyls podocaysics acids anhydrides livers hormones atherosclerosis | |
| 705502 | Aconitase Assay Kit | - |
|
2008-10-21 | 279.184417127071 | aconitase-assay-kit | iron-sulfurs proteins catalyzes isomerizations isocitrates cis-aconitates pro-oxidants oxidatives damages injury tissues homogenates cells lysates a-ketoglutarate alpha-ketoglutarate .alpha.-ketoglutarates dehydrogenases NADPH assays | ||||
| 10005254 | AFMK | 52450-38-1 | >98% |
|
2004-10-28 | 2.319240932020 | afmk | melatonin metabolites metabolism radicals scavengers neurotransmitters eukaryotes circadean rhythms antioxidants plasma synthesis endocrinology neurochemistry | |||
| 10009350 | Aldehyde Reactive Probe | 139585-03-8 | ≥98% |
|
2008-08-26 | 7.327900552486 | aldehyde-reactive-probe | O-(Biotinylcarbazoylmethyl) Hydroxylamine; ARP | DNA damages AP sites synthesis mutations ROS biotin oxidative stress detection detecting | ||
| 600170 | Aldehyde Site (DNA and Protein) Detection Kit | - |
|
2009-12-10 | 244.669128771780 | aldehyde-site-dna-and-protein-detection-kit | CBAs assays kits measuring measurement oxidative damage reactive oxygen species ROS proteins degradation mitochondria mitochondrial DNA deoxyribonucleases nuclear mutations genomic cancers liquid chromatography gas LC-mass spectrometry GC-mass antibody-based immunoassays repair glycosylases comet assays slot blot aldehydes reactive probes ARP O-(biotinylcarbazoylmethyl) hydroxylamine biotin-tagged avidin-conjugated probes sites cells Epigallocatechin Gallate (EGCG) culture medium hydrogen peroxides H2O2 positive controls high throughput screenings HTS | ||||
| 10012597 | Allopurinol | 315-30-0 | ≥98% |
|
2009-12-07 | 21.672928176796 | allopurinol | xanthine oxidoreductase oxidation hypoxanthine uric acids dehydrogenases oxidases superoxides inhibitors inhibition inhibits gout hyperuricemia oxypuriol | |||
| 82225 | AMVN | 4419-11-8 | >98% |
|
2004-09-28 | 205.915651144435 | amvn | free radicals generators synthetic azo carbon-centered initiators tocopherol antioxidants lipids peroxidation trapping | |||
| 10006212 |
AN- |
- | >98% |
|
2004-12-09 | 164.979502762431 | an-7 | .alpha.-lipoic acids antioxidants cofactors diabetes glucose metabolism cyclic disulfides dithiol decarboxylation lipophilic analogs myocytes citric endocrinology | |||
| 709001 | Antioxidant Assay Kit | - |
|
2004-04-14 | 522.675024861878 | antioxidant-assay-kit | measures kits oxidative stress antioxidants total endogenous food-derived extracellular fluids plasma serum urine saliva cell lysates analysistools:antiox assays | ||||
| 10157 | APF | - | >98% |
|
2004-08-24 | 10.914022099447 | apf | fluorescence oxidants oxidation radicals gerontology free fluorescent biological hydrogen peroxide H2O2 NO nitric oxides DCDHF dichlorohydrofluorescein | |||
| 700420 | Ascorbate Assay Kit New | - |
|
2010-09-01 | 0E-12 | ascorbate-assay-kit | L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit | kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD | |||
| 13644 | Aspalatone Exclusive | 147249-33-0 | ≥98% |
|
✓ | 2010-02-19 | 64.697395547684 | aspalatone | Acetylsalicylic Acid Matol ester | antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles | |
| 70685 | Astaxanthin | 7542-45-2 | >98% |
|
40.308508287293 | astaxanthin | Carophyll Pink; Lucantin Pink; NatuRose; Ovoester; AstaREAL; AstaXin; BioAstin | antioxidants carotenoids marine reactive oxygen species natural ROS | |||
| 10005292 | Atherosclerosis Product Pack | - | 2004-09-09 | 6.775257826887 | atherosclerosis-product-pack | Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs | |||||
| 60924 | Azelaoyl PAF | - | >98% |
|
95.509960536701 | azelaoyl-paf | PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors | ||||
| 70610 | Baicalein | 491-67-8 | >95% |
|
23.246939226519 | baicalein | flavonoid scutellaria baicalensis georgi 12- LO inhibitors lipoxygenases lipids peroxidation apoptosis | ||||
| 89910 | BHT | 128-37-0 | >98% |
|
2004-03-30 | 7.447941988950 | bht | Butylated Hydroxy Toluene | antixoidants | ||
| 60929 | Butenoyl PAF | - | >98% |
|
10.307756906077 | butenoyl-paf | ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis | ||||
| 89800 | Carnosol | 5957-80-2 | >96% |
|
96.884475138121 | carnosol | antioxidants tumors herbs carcinogenesis rosemary Rosmarinus officinalis extracts polyphenolic inhibits inhibitors inhibition | ||||
| 707002 | Catalase Assay Kit | - | 549.369533456108 | catalase-assay-kit | CAT | peroxidases reductases oxidative stress injury assays kits detoxification antioxidants CAT H2O2 hydrogen peroxide analysistools:catalase | |||||
| 70940 |
(+)- |
88191-48-4 | >98% |
|
22.586378146101 | -catechin-hydrate | D-(+)-Catechin (hydrate); Cyanidol (hydrate); Catechuic Acid (hydrate) | polyphenolic flavonoids antioxidants lipid peroxidation oxidative injury stress inhibitors inhibits COX-1 COX1 PGHS-1 PGHS2 cyclooxygenases prostaglandin synthases cyclooxygenase-2 synthase-2 antitumor procyanidin d-catechin inhibition hydrates | |||
| 10006546 | CAY10465 | 688348-33-6 | >98% |
|
2005-09-09 | 10.871038674033 | cay10465 | resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar | |||
| 10009536 | CAY10512 | 139141-12-1 | >97% |
|
2007-07-18 | 12.972464088398 | cay10512 | analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis | |||
| 10012682 | CAY10585 | 934593-90-5 | ≥97% |
|
2008-11-06 | 40.265179558011 | cay10585 | Hypoxia Inducible Factor-1α Inhibitor | HIF-1α HIF1α hypoxia cancers transcriptions factors VEGFs erythropoietin inhibitors inhibits inhibition | ||
| 300011 | CD36 Blocking Peptide | - | 12.680096685082 | cd36-blocking-peptide | Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb | type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma CD-36 western blots blotting atherosclerosis controls peptides peroxisome proliferator-activated GP-IV GP-4 GP-3b GP-IIIb | |||||
| 188150 | CD36 Monoclonal Antibody (Clone JC63.1) | - | 36.202174427781 | cd36-monoclonal-antibody-clone-jc63-1 | Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb | antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC | |||||
| 10009893 | CD36 Monoclonal Antibody (Clone JC63.1) (azide free) | - | 2010-03-03 | 106.303264491800 | cd36-monoclonal-antibody-clone-jc63-1-azide-free | GPIV; oxLDL; Thrombospondin Receptor; Hexarelin Receptor; GPIIIb | antibodies antisera antiserum flow cytometry PPAR.gamma. CD-36 glycoprotein fatty acids PPARgamma blocking apoptosis oxidative injury atherosclerosis FC leukemia lymphocytic | ||||
| 10009870 | CD36 Monoclonal FITC Antibody (Clone JC63.1) | - | 2008-03-17 | 38.674479742172 | cd36-monoclonal-fitc-antibody-clone-jc63-1 | Thrombospondin Receptor; Hexarelin Receptor; GPIIIb; OxLDL Receptor; GPIV | type-B atherosclerotic lesions fatty acids PPAR.gamma. expression flow cytometry immunocytochemistry FC ICC | ||||
| 100011 | CD36 Polyclonal Antibody | - |
|
25.232320441989 | cd36-polyclonal-antibody | Thrombospondin Receptor; oxLDL Receptor; Hexarelin Receptor; GPIV; GPIIIb | type scavengers receptors atherosclerotic lesions glycoprotiens membranes PPAR.gamma. PPARgamma antibodies atherosclerosis CD-36 western blots blotting peroxisome proliferator-activated GP-IIIb GP-IV GP-3b GP-4 WB atherosclerosis immunoblotting | ||||
| 70950 | Celastrol | 34157-83-0 | >98% |
|
2004-02-12 | 54.439765193370 | celastrol | triterpenes triterpenoids tryptergium wilfordic chinese thunder of god peroxidation inhibition inhibits flavonoids antioxidants lipids | |||
| 9000595 |
CEP- |
- | ≥99% deuterated product |
|
✓ | 2010-08-23 | 0E-12 | cep-lysine-d4 | Docosahexaenoic acid DHA oxidative stress 2-(ω-carboxyethyl)pyrrole CEP carboxyethylpyrrole advanced glycation end products biomarkers age-related macular degeneration deuterateds internal standard GC LC chromatography mass spectrometry GC-MS LC-MS GC/MS LC/MS deuterium | ||
| 10011286 | Chenodeoxycholic Acid | 474-25-9 | ≥95% |
|
2009-02-25 | 0.099447513812 | chenodeoxycholic-acid | Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA | FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA | ||
| 70930 | Chlorogenic Acid | 327-97-9 | >95% |
|
11.711316758747 | chlorogenic-acid | NSC 407296; Heriguard; 3-O-Caffeoylquinic acid | antioxidants acids plants metabolism polyphenolic | |||
| 48001 | Cholesteryl Linoleate Hydroperoxides | - | >98% hydroperoxide content |
|
11.495767955800 | cholesteryl-linoleate-hydroperoxides | autoxidation atherosclerosis LDL HDL hydroperoxy fatty acids | ||||
| 10004235 |
cis- |
61434-67-1 | >98% (may contain 1-5% trans) |
|
2008-02-05 | 26.430033149171 | cis-resveratrol | (Z)-Resveratrol | antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins | ||
| 81025 | Curcumin | 458-37-7 | >90% |
|
27.155653775321 | curcumin | Turmeric Yellow; Indian Saffron | anti-oxidant anti-imflammatory NOS nitric oxide synthase | |||
| 81025.1 | Curcumin (technical grade) | 458-37-7 | >65% |
|
7.006243093922 | curcumin-technical-grade | Turmeric Yellow; Indian Saffron | anti-oxidant anti-imflammatory NOS nitric oxide synthase | |||
| 10009660 | CYPMPO | - | >95% |
|
2007-07-25 | 20.679263351750 | cypmpo | free radicals spin trap superoxides oxidative stress ESR EPR xanthine oxidase DEPMPO DMPO hydroxyl neutrophils adduct | |||
| 10005166 | Daidzein | 486-66-8 | >98% |
|
2004-07-28 | 14.654346224677 | daidzein | Isoflavone | legumes phytoestrogenics genisteins estrogens agonists antagonists antioxidants inhibits inhibitors inhibition plants proteins kinases | ||
| 13382 |
DAz- |
- | ≥98% |
|
2009-11-05 | 71.740164300991 | daz-2 | Daz1 Daz-1 Daz 1 sulfenic acids click chemistry ROS oxidative stress cysteine oxidation LC-MS/MS analysis standinger | |||
| 10009081 | Didox Exclusive | 69839-83-4 | >98% |
|
✓ | 2007-01-16 | 13.587292817679 | didox | antioxidants hydroxamic acids apoptosis cancers cells polyhydroxylated aromatic ocidative injury brains HIV dementia bcl-2 | ||
| 10009986 | dimethoxy Curcumin | 160096-59-3 | ≥90% |
|
2007-08-03 | 35.433591160220 | dimethoxy-curcumin | curcumins cancers ASCJ9 antitumors anti-tumor phytochemicals turmeric inhibits inhibition inhibitory growth expression cells ASC-J9 | |||
| 62237 |
Diphenyl- |
110231-30-6 | >98% |
|
2006-07-25 | 62.428694751381 | diphenyl-1-pyrenylphosphine | DPPP | hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis | ||
| 10005728 |
DL- |
1077-28-7 | >95% |
|
2004-10-26 | 157.265723756906 | dl-lipoic-acid | Thioctic acid | decarboxylation reactions antioxidants cyclic disulfides citric acids cycles radicals scavengers glutathione metal chelators dithiol | ||
| 10006436 | DMPO New | 3317-61-1 | ≥98% |
|
2010-07-19 | 185.633627992633 | dmpo | 5,5-Dimethyl-1-Pyrroline N-Oxide | spins traps free radicals electrons resance immunospin immun-spin traps trapping in vitro in vivo bi-layers bilayers low toxicity | ||
| 10006170 | DMPO Nitrone Adduct Polyclonal Antiserum | - | 2004-11-24 | 198.575573204419 | dmpo-nitrone-adduct-polyclonal-antiserum | 5,5-dimethyl-1-pyrroline-N-oxide Nitrone Adduct | proteins radicals EPR spin trap antibodies antisera antiserum western blots blotting WB ELISA enzyme-linked immunosorbent immunoassays adducts electrons paramagnetics resonance antibodies antibody immunodetection immunoblotting assays | ||||
| 70530 | Ebselen | 60940-34-3 | >99% |
|
138.423093922652 | ebselen | glutathione peroxidase peroxynitrite oxidative injury stress cyclooxygenases lipoxygenases LOX 5-LO 12-LO 15-LO cyclooxygenases inhibitors COX-1 COX-2 cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits mimics scavengers | ||||
| 10012298 | Ebselen Oxide Exclusive | 104473-83-8 | ≥98% |
|
✓ | 2009-05-07 | 37.033646408840 | ebselen-oxide | NSC 639772 | antioxidants oxidants ebselen selenoxide scavenger peroxynitrite cerebral infarctions negative controls | |
| 10011192 | Elesclomol Exclusive | 488832-69-5 | ≥98% |
|
✓ | 2009-04-23 | 6.298637200736 | elesclomol | STA 4783; NSC 174939 | cancer apoptosis melanoma ROS oxidative stress Hsp70 metallothionein STA-4783 874477-56-2 | |
| 10004111 | Endothelial Lipase (human) Blocking Peptide | - | 2004-01-26 | 27.877071823204 | endothelial-lipase-human-blocking-peptide | EDL; EL | peptides western blots blotting wb icc immunocytochemistry atherosclerosis controls special:month specialdiscount:15 specialstart:2008-03-01 specialend:2008-03-31 | ||||
| 10010380 |
ent- |
- | ≥98% |
|
2008-04-24 | 15.519401473296 | ent-8-iso-15-s-prostaglandin-f2 | ent-8-iso-15-epi-PGF2α; ent-15-epi-F2t-Isoprostane | inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane prostaglandins | ||
| 10011545 |
ent- |
- | >98% |
|
2008-05-28 | 14.832209944751 | ent-8-iso-prostaglandin-f2 | ent-8-epi PGF2α; ent-15-F2t-Isoprostane; ent-8-iso PGF2α | vasoconstrictor oxidative stress isoprostanes prostaglandins iPs PGF2a PGF2.alpha. | ||
| 10011721 |
ent- |
- | ≥99% deuterated product |
|
✓ | 2008-08-11 | 14.911408839779 | ent-8-iso-prostaglandin-f2-d9 | ent-8-epi PGF2α-d9; ent-15-F2t-Isoprostane-d9; ent-8-iso PGF2α-d9 | deuterated deuterium inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane GC/MS GC-MS LC/MS LC-MS mass spectrometry | |
| 10008294 |
ent- |
65085-69-0 | >98% |
|
2006-03-30 | 81.990966850828 | ent-prostaglandin-e2 | ent-PGE2 | prostaglandins enantiomers enzymatically-derived optically free radical-catalyzed peroxidation arachidonates racemic in vitro in vivo oxidative stress isoprostanes 15-E2t-IsoP 8-iso endoperoxides | ||
| 10008122 |
ent- |
54483-31-7 | >98% |
|
2006-03-30 | 53.302154696132 | ent-prostaglandin-f2 | (-)-Prostaglandin F2α; ent-PGF2α | prostaglandins enantiomers optically free radical-catalyzed peroxidation racemic isoprostanes lipids oxidative stress human urine cigarette smokers hpercholesterolemia COX cyclooxygenase oxidative stress | ||
| 10010382 |
ent- |
- |
|
2008-04-08 | 216.899208103131 | ent-prostaglandin-f2-eia-kit | ent-PGF2α EIA Kit | prostaglandins PGH2 PGs COX cyclooxygenases reproduction smooth muscles contractions urine enantiomers quantification measures kits eias enzyme immunoassays ELISAs assays | |||
| 70935 | Epigallocatechin Gallate | 989-51-5 | >98% |
|
32.082628255722 | epigallocatechin-gallate | Tea catechin; EGCG | phenolic flavonoids antioxidants lipoproteins oxidative injury stress plants green black teas oxidation nitric oxide | |||
| 10271 | EUK 118 | 186299-34-3 | ≥95% |
|
2008-07-28 | 17.483425414364 | euk-118 | superoxide free radicals hydrogen peroxide scavenger catalase SOD superoxide dismutase ROS reactive oxygen species | |||
| 12500 | EUK 124 | 186299-35-4 | ≥95% |
|
2008-07-24 | 16.712651933701 | euk-124 | superoxide free radicals hydrogen peroxide scavenger catalase SOD superoxide dismutase ROS reactive oxygen species EUK124 EUK-124 | |||
| 10006329 | EUK 134 | 81065-76-1 | >98% |
|
2005-03-02 | 34.260773480662 | euk-134 | salen manganese SOD ROS catalse stroke oxidative injury porphyrin scavengers peroxynitrites superoxides hydrogen peroxides arteries artery cerebral H2O2 infarct volumes EUK 134 EUK-134 EUK134 | |||
| 75854 | FeTMPyP | 133314-07-5 | >98% |
|
18.232872928176 | fetmpyp | porphyrin peroxynitrite | ||||
| 10005167 | Genistein | 446-72-0 | >98% |
|
2004-08-04 | 14.062975532754 | genistein | isoflavonoids phytoestrogenics legumes glycosides carcinogenic tumors inhibits inhibition inhibitors estrogenic isoflavones uterine DES diethylstilbestrol histones H2B endocrine tyrosine chemopreventitive | |||
| 703002 | Glutathione Assay Kit | - |
|
642.518220412910 | glutathione-assay-kit | GSH Assay Kit | GSH GSSG peroxidase reductase oxidative stress injury assays kits detoxification analysistools:gsh | ||||
| 703102 | Glutathione Peroxidase Assay Kit | - |
|
563.318282270215 | glutathione-peroxidase-assay-kit | GPx Assay Kit | GPx oxidative injury stress free radicals assays kits GR GSSG GSH hydroperoxides selenocysteine GSH GSSG analysistools:gshases | ||||
| 703202 | Glutathione Reductase Assay Kit | - |
|
311.681722456938 | glutathione-reductase-assay-kit | GR Assay Kit | antioxidants oxidative stress injury activity assays kits GR GSSG GSH oxidized analysistools:gshases | ||||
| 703302 |
Glutathione S- |
- |
|
314.689613259668 | glutathione-s-transferase-assay-kit | GST Assay Kit | GST assays kits S-transferases GSH activity detoxification antioxidants oxidative injury stress enzymes analysistools:gshases | ||||
| 10005256 | GPx4 Blocking Peptide | - | 2004-12-27 | 135.838308011049 | gpx4-blocking-peptide | Glutathione Peroxidase 4; PhGPx | antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides glutathione peroxidases selenium-dependent selenoprotein SnGPx | ||||
| 10005258 | GPx4 Polyclonal Antibody | - |
|
2004-12-29 | 130.650687538367 | gpx4-polyclonal-antibody | Glutathione Peroxidase 4; PhGPx | WB western blots blotting synthases antibodies antisera antiserum glutathione peroxidases selenium-dependent selenoprotein SnGPx phospholipases hydroperoxides monomeric homotetramer immunoblotting | |||
| 10011424 | GRP94 Monoclonal Antibody (Clone 9G10) | - | 2008-04-23 | 2.219152854512 | grp94-monoclonal-antibody-clone-9g10 | GP96; Glucose Regulated Protein 94 | chaperones heat shock proteins immunoblots antibodies glucose stress oxidative WB IP FC western blots immunoblotting immunoprecipitation flow cytometry antiserum blotting | ||||
| 70430 | Guaiacol | 90-05-1 | >98% |
|
1.863093922652 | guaiacol | oxidation heme hydroperoxidases 2-methoxy-phenol hydroperoxides 2-methoxyphenols phenolic guaiac resin cyclooxygenases COX PGHS prostaglandins synthases | ||||
| 10006084 | Hesperetin | 520-33-2 | >98% |
|
2005-02-16 | 17.510257826887 | hesperetin | hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis | |||
| 34002 |
(±)- |
- | >98% for each compound | 9.651854775059 | -hete-hplc-mixture | racemic hydroxy acids arachidonic autoxidation (+/-)-HETEs fatty chromatography (+/-)HETEs | |||||
| 10006910 |
HIF- |
- |
|
2007-10-31 | 65.679592541436 | hif-1-transcription-factor-assay-kit | Hypoxia-inducible Factor-1α | tf HIF-1alpha factors HIF1.alpha. cancers basic-helix-loop-helix bHLH cellular oxygen homeostasis cells tissues ischemia infections embryos tumors drugs target breast prostate cardiovascular diseases nuclear extracts whole lysates assays kits ELISAs enzyme-linked immunosorbent double stranded dsDNA HIF1 HIF1alpha HIF1 alpha HIF-1 alpha | |||
| 10159 | HPF | - | >98% |
|
2005-09-09 | 10.716749539595 | hpf | cell-permeable fluorescent fluorescence dyes detects detection highly reactive oxygen species radicals neurodegenertion aging cancer infectious diseases reagents free 2,7-dichlorohydrofluorescein DCDHF hydrogen peroxide H2O2 aromatics amino-derivatives oxidation hROS hydroxyls peroxynitrites peroxidases hypochlorites ions NO nitric oxides superoxides oxidants molecules biologicals | |||
| 600050 |
Hydrogen Peroxide Cell- |
- |
|
2009-03-18 | 355.714571823204 | hydrogen-peroxide-cell-based-assay-kit | H2O2 Fluorometric Assay Kit | kits assays cells cell-based measuring measurement oxidative stress injury oxygen metabolisms oxidizer oxidizing ROS reactive species cytotoxic agents regulates regulators signals transductions fluorometrics cultured cells ADHP HRPfluorescents resorufins scavengers | |||
| 706011 | Hydrogen Peroxide (urinary) Assay Kit | - |
|
209.175428176795 | hydrogen-peroxide-urinary-assay-kit | H2O2 Assay Kit | peroxidase reductase oxidative stress injury assays detoxification measures kits analysistools:h2o2 assays | ||||
| 44001 | Hydroperoxy HPLC Mixture | - | >98% for each compound | 15.455810313075 | hydroperoxy-hplc-mixture | HPLC 12-HpETEs 5-HpETEs 15-HpETEs hydroperoxides | |||||
| 89420 | Hydroxy Linoleins | - | >98% (A mixture of 132 isomers) |
|
4.204318600368 | hydroxy-linoleins | fatty acids trilinoleins autoxidation lipid peroxidation triglycerides | ||||
| 89360 | Hydroxymethyl Uracil | 4433-40-3 | >98% |
|
6.567090239410 | hydroxymethyl-uracil | oxidative injury stress DNA hydroxyl radicals Fenton reactions | ||||
| 13323 |
IM- |
861891-50-1 | ≥95% |
|
2009-10-14 | 0.142857142857 | im-54 | inhibitors necrosis necrotic cells death peroxide HL-60 leukemia apoptosis PKC S6K1 protein kinases C S6 1 indolymaleimide | |||
| 16230 |
iPF2α- |
331962-00-6 | >98% |
|
2006-07-27 | 23.217941988950 | ipf2-iv | isoprostanes prostaglandins lipids peroxidation arachidonic acids PUFAs polyunsaturated fatty oxidative stress injury | |||
| 316230 |
iPF2α- |
- | ≥99% deuterated product |
|
28.040211786372 | ipf2-iv-d4 | 1-trihomo-18,19,20-trinor-8-iso-15(R),2Z,6E-Prostaglandin F2α-d4 | GC/MS deuteriums isotopes 8-isoprostanes iPF2.alpha.-IV-d4 iPF2alpha-IV-d4 internal standards LC/MS LC-MS GC-MS mass spectroscopy deuterated oxidative injury prostaglandins | |||
| 316300 |
iPF2α- |
214977-79-4 | ≥99% deuterated product |
|
33.231862667719 | ipf2-vi-d4 | 8-iso-5(R),6E,14Z-Prostaglandin F2α-d4 | deuteriums isotopes 8-isoprostanes iPF2.alpha.-VI-d4 iPF2alpha-VI-d4 lipid peroxidation oxidative ipf2a injury stress prostaglandins deuterated iPF2a-VI-d4 pgf2a deuterium GC/MS GC-MS LC/MS LC-MS mass specrometry | |||
| 516301 |
iPF2α- |
- |
|
146.154844878877 | ipf2-vi-eia-kit | iPF2α-VI ELISA Kit | solid plates prostaglandins measures kits eias enzyme immunoassays ELISAs ipf2a-VI ipf2aVI isoprostanes assays | ||||
| 62935 |
KDdiA- |
439904-34-4 | >98% |
|
✓ | 2005-09-09 | 10.425159371015 | kddia-pc | CD36 ligands oxidized oxLDL low density lipoproteins particles cytotoxics pro-atherogenic phosphatidylcholines species short-chain fatty acids sn-2 scavengers receptors structural determinants binding affinity atherosclerosis | ||
| 62945 |
KOdiA- |
439904-33-3 | >98% |
|
✓ | 2004-01-28 | 42.215521178637 | kodia-pc | oxidative injury lipids oxLDL oxidized low-density lipoproteins phosphatidylcholines CD36 CD-36 scavengers receptors binding atherosclerosis | ||
| 89430 | Linolein Hydroperoxides | - | >98% (A mixture of 132 isomers) |
|
4.024530386740 | linolein-hydroperoxides | trilinoleins autoxidation atherosclerosis isomers hydroperoxy fatty acids | ||||
| 705002 | Lipid Hydroperoxide (LPO) Assay Kit | - |
|
332.811721915285 | lipid-hydroperoxide-lpo-assay-kit | lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress atherosclerosis assays | |||||
| 10006594 | Losartan (potassium salt) | 124750-99-8 | >98% |
|
2005-05-10 | 4.783425414365 | losartan-potassium-salt | MK 954; DuP 753 | AT1 receptors antagonists angiotensins II type 1 hormones regulates blood pressure regulating hypertension atherosclerosis renal functions vasodilation vasodilating platelets neutrophils aggregation endothelium losartans losartan potassium | ||
| 10005174 | Matairesinol | 580-72-3 | >95% |
|
2004-07-28 | 162.081012891344 | matairesinol | lignans plants antioxidants cancer oxidative injury stress enterobacterial fiber dietary enteric isoprostanes enterolactone | |||
| 13320 |
MCI- |
89-25-8 | ≥98% |
|
2010-07-15 | 0E-12 | mci-186 | NSC 2629; Edaravone | free radical scavengers inhibitors inhibits inhibition ischemia-reperfusion injury transplants infections traumatic brain injury injuries strokes reactive oxygen species apoptosis Norantipyrine Norphenazone Radicut 206195-95-1 115566-83-1 72134-66-8 62495-97-0 52224-17-6 12235-58-4 methylphenylpyrazolone NSC 26139 NSC 12 Edarabone | ||
| 600160 | Methionine Sulfoxide Immunoblotting Kit | - |
|
2009-12-17 | 143.321805433729 | methionine-sulfoxide-immunoblotting-kit | MetO Immunoblotting Kit | proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 | |||
| 75850 | Mn(III)TBAP | - | >95% |
|
15.322523020257 | mn-iii-tbap | SOD mimic superoxide dismutase | ||||
| 75852 | Mn(III)TMPyP | - | >95% |
|
22.607223756905 | mn-iii-tmpyp | SOD mimetic peroxynitrite superoxide dismutase | ||||
| 585001 | Myeloperoxidase (human) EIA Kit | - |
|
2009-05-05 | 52.057329650091 | myeloperoxidase-human-eia-kit | MPO (human) EIA Kit | myeloperoxidases controls standards EIAs ELISAs enzymes immunometrics assays leukocytes oxidants atherosclerotic atherosclerosis plaques prothrombogenicity cytotoxic cytotoxins nitric oxides vasocontrictions vasocontrictors plasma blood ACS acute coronary syndromes cardiac myocardial infarction revascularization death assays | |||
| 10012600 | Myricetin | 529-44-2 | >98% |
|
2009-02-20 | 13.802596685083 | myricetin | NSC 407290; Cannabiscetin | flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 | ||
| 89540 | Nitrotyrosine | 621-44-3 | >99% |
|
23.745469613260 | nitrotyrosine | peroxynitrite oxidative injury nitration stress 3-nitrotyrosine protein 3-nitro-L-tyrosine | ||||
| 389549 | Nitrotyrosine Affinity Sorbent | - | 22.725082872928 | nitrotyrosine-affinity-sorbent | immunoprecipitation nitrated proteins sorbents IPP NO peroxynitrite nitric oxide Western blots blotting matrix resins IP antibodies | ||||||
| 89542 | Nitrotyrosine BSA | - | 20.441790055248 | nitrotyrosine-bsa | Peroxynitrite-treated BSA | nitrotyrosine controla western blots blotting | |||||
| 189542 | Nitrotyrosine Monoclonal Antibody | - |
|
49.696519337016 | nitrotyrosine-monoclonal-antibody | peroxynitrite nitric oxide superoxide oxidative injury stress Alzheimer's diseases antibodies NO western blots blotting WB nitration proteins antisera antiserum IHC immunohistochemistry immunoprecipitation IP atherosclerosis immunoblotting EIA enzyme immunoassays | |||||
| 10006966 |
Nitrotyrosine Monoclonal Antibody - |
- | 2005-04-15 | 21.941546961326 | nitrotyrosine-monoclonal-antibody-biotinylated | antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays | |||||
| 10006778 | Nitrotyrosine (Peptide) Polyclonal Antibody | - | 2005-05-04 | 15.732454617206 | nitrotyrosine-peptide-polyclonal-antibody | antibodies western blots blotting WB antisera antiserum peroxynitrite nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress immunoblotting | |||||
| 10189540 | Nitrotyrosine Polyclonal Antibody | - |
|
2.618784530387 | nitrotyrosine-polyclonal-antibody | 189540 peroxynitrite antibodies western blots blotting nitric oxide nitration proteins NO superoxide WB alzheimer's diseases oxidative injury stress antisera antiserum immunoblotting | |||||
| 13521 | Oxalomalic Acid (sodium salt) | 89304-26-7 | ≥95% |
|
2010-02-05 | 119.273092485927 | oxalomalic-acid-sodium-salt | aconitases citric acids glutamate oxidative injuries inhibitors inhibition inhibits oxalomalics oxaloacetate glyoxylate iron regulatory proteins IRP | |||
| 34004 | Oxidized Lipid HPLC Mixture | - | >98% for each compound | 12.285917740945 | oxidized-lipid-hplc-mixture | ROS peroxidation LDL atherosclerosis autoxidation reactive oxygen species (+/-)9-HODEs (+/-)13-HODEs esters (+/-)15-HETEs (+/-)-HODEs (+/-)-HETEs hydroxy fatty acids racemic (+/-)HODEs (+/-)HETEs cholesteryl esters | |||||
| 10007893 |
oxLDL- |
- | 2006-01-24 | 58.792928176796 | oxldl-2gpi-human-elisa-kit | Oxidized low-density lipoprotein-β2 Glycoprotein I (human) EIA kit | ox-ldl ox ldl eia atherosclerosis enyzme immunoassay territory:americas assays | ||||
| 62924 |
PAz- |
117746-89-1 | >98% |
|
9.363931860036 | paz-pc | Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC | PPAR.gamma. PPARgamma receptors thiazolidinediones binding sites atherosclerosis | |||
| 10007186 | PCSK9 (human) Blocking Peptide | - | 2006-01-11 | 12.167821625887 | pcsk9-human-blocking-peptide | NARC-1 | proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi cancer cells tissues | ||||
| 10009581 | PCSK9 (murine) Blocking Peptide | - | 2007-01-22 | 13.817720994475 | pcsk9-murine-blocking-peptide | Proprotein Convertase Subtilisin Kexin 9; NARC-1 | neural apoptosis regulated convertase 1 proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols cancer cells | ||||
| 10008811 | PCSK9 (murine) Polyclonal Antibody | - |
|
2007-01-22 | 15.063116022099 | pcsk9-murine-polyclonal-antibody | Proprotein Convertase Subtilisin Kexin 9; NARC-1 | immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting | |||
| 10010518 | PD 146176 | 4079-26-9 | ≥98% |
|
2009-02-25 | 78.610386740332 | pd-146176 | NSC 168807 | atherosclerosis 15-LOs 15-lipoxygenases oxidant injury injuries apoptosis amyloid β proteins inhibitors inhibits inhibitions Alzheimers disease oxidative stress pd146176 | ||
| 10006341 | PDM 11 | - | >98% |
|
2005-03-23 | 10.793469613259 | pdm-11 | resveratrol analogs analogues aryl hydrocarbons receptors anatagonists AhRs ligand-dependents ligands xenobiotics PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar | |||
| 10006342 | PDM 2 | 688348-25-6 | >98% |
|
2005-03-29 | 11.900342541436 | pdm-2 | AhRs antagonists stilbenes dioxins aryl hydrocarbons receptors ligand-dependent transcription factors resveratrol analogs ligands xenobiotics PDM2 PDM-2 estrogen poisonings xenobiotics polyaromatics soot coal tar cancers | |||
| 10005983 | Pentafluorobenzenesulfonyl fluorescein | 728912-45-6 | >98% |
|
2005-02-22 | 15.762108655617 | pentafluorobenzenesulfonyl-fluorescein | fluoresceins hydrogen peroxides oxidative stress fluorescents probes ROS reactive oxygen species perhydrolysis H2O2 | |||
| 10044 | PGPC | 89947-79-5 | >98% |
|
2004-01-21 | 9.485155121122 | pgpc | PPAR.gamma. PPARgamma oxidized LDL lipds agonists atherosclerosis nuclear receptors thiazolidinediones sites peroxisome low-density lipoproteins e-selectin vcam1 vcam-1 binding | |||
| 10031 |
POV- |
121324-31-0 | >98% |
|
19.672787543947 | pov-pc | 2-(5-oxovaleryl) Phosphatidylcholine | oxidative injury lipids stress oxLDL oxidized low-density lipoproteins CD36 CD-36 PMNLs polymorphonuclear leukocytes atherosclerosis phosphatidylcholines scavengers receptors LPS-binding affinity potent structural determinant inhibits inhibition inhibitors lipopolysaccaride atherosclerosis | |||
| 75751 | PPA | - | >98% |
|
8.088397790055 | ppa | peroxidase HPLC standard PPHP cylcooxygenase | ||||
| 75750 | PPHP | 87864-20-8 | >98% |
|
39.059254143646 | pphp | peroxidase substrate cyclooxygenase | ||||
| 11510 | Prostaglandin Bx Exclusive | 39306-29-1 | Mixture of oligomers | ✓ | 6.010994475138 | prostaglandin-bx | PGBx | PGBx free radicals antioxidants prostaglandins | |||
| 10005020 | Protein Carbonyl Assay Kit | - | 2004-11-19 | 435.592817679558 | protein-carbonyl-assay-kit | reactive oxygen species ROS Fe2+ Cu2+ metal-catalyzed oxidation lysines arginines pralinse histidines 2,4-dinitrophenylhydrazines DNPH Schiff bases plasma serum tissues homogenates oxidized proteins hydrazones colorimetric assays kits | |||||
| 10011353 | Protocatechuate Dioxygenase | - | ≥90% | 2008-09-19 | 1.857458563536 | protocatechuate-dioxygenase | PCD; Protocatechuate 3,4-Dioxygenase; Aromatic Dioxygenase | proteins PCA protocatechuate bacterial overexpression | |||
| 13000 | Pterostilbene | 537-42-8 | ≥98% |
|
2009-09-09 | 13.886543014995 | pterostilbene | 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene | resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory | ||
| 10009594 | Pyocyanin | 85-66-5 | >98% |
|
2007-07-12 | 11.113812154696 | pyocyanin | Pyocyanine; Sanazin; Sanasin | Pseudonomas aeruginosa phenazine metabolite neutrophil apoptosis Cystic fibrosis | ||
| 10005169 | Quercetin | 117-39-5 | >95% |
|
2004-08-04 | 13.796331491712 | quercetin | flavonoid plants fruits glycosides carcinogens carcinogenic inhibits inhibitors inhibition phosphodiesterases antioxidants rutin | |||
| 10006415 |
Ro 48- |
161582-11-2 | >98% |
|
2005-06-01 | 30.147645027624 | ro-48-8071 | monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis | |||
| 70900 | Rosmarinic Acid | 20283-92-5 | >98% |
|
25.723139963167 | rosmarinic-acid | antioxidants inflammation lipids peroxidation | ||||
| 10006518 |
S- |
- | 2005-11-29 | 169.407329074585 | s-nitrosylated-protein-detection-kit | SNO Detection | NOs nitric oxides synthases oxidation oxidative reactive nitrogen species RNS thiol SH groups signalling proteins kits measures measurements S-nitrosation nitrosation S-nitrosylation nitrosylation assays | ||||
| 10012555 | Sodium Hydrogen Sulfide (hydrate) | 207683-19-0 | ≥65% |
|
2009-09-03 | 7.244880294659 | sodium-hydrogen-sulfide-hydrate | Sodium Hydrosulfide; NSC 158264; NaHS | hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 | ||
| 10009642 |
SOTS- |
223507-96-8 | >80% |
|
2008-06-09 | 2.414364640884 | sots-1-technical-grade | Superoxide Thermal Source; Di-(4-Carboxybenzyl)Hyponitrite | superoxide radical anion hydroperoxyl hydrogen peroxide hydroxyl oxidative stress superoxide dismutase thermal sources SOTS1 SOTS-1 Azo compounds SOD | ||
| 500431 |
STAT- |
- |
|
151.856591160221 | stat-8-isoprostane-eia-kit | STAT-8-Isoprostane ELISA Kit; iPF2α-III Alkaline Phosphatase EIA Kit; STAT-8-iso Prostaglandin F2α EIA Kit; STAT-8-epi Prostaglandin F2α EIA Kit | solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays | ||||
| 706002 | Superoxide Dismutase Assay Kit | - |
|
840.558221685082 | superoxide-dismutase-assay-kit | SOD Assay Kit | assays kits Cu-Zn-SOD CuZn-SOD catalyzes catalysis Cu/Zn-SOD Mn-SOD Fe-SOD peroxynitrite copper/zinc manganese iron ALS dismutases metalloenzymes antioxidants oxidative injury stress cellular cytosolic mitochodrial extracellular amytrophic lateral sclerosis alzheimer's parkinson's huntington's diseases analysistools:sod | ||||
| 10009055 | TBARS Assay Kit | - |
|
2006-10-13 | 549.846512430939 | tbars-assay-kit | Thiobarbituric Acid Reactive Substances Assay Kit | assays kits MDA malodialdehyde lipid peoxidation cellular injury oxidative stress thiobarbitruic acid reactive substances MDA-TBA adduct colorimetrically | |||
| 13083 | ThioFluor 623 | 1004324-99-5 | ≥98% |
|
2009-03-16 | 62.926961325967 | thiofluor-623 | Fluorescent Thiol Probe | thiols fluorophores cells permable cell-permeable | ||
| 700340 | Thiol Detection Assay Kit New | - |
|
2010-04-27 | 0E-12 | thiol-detection-assay-kit | kits assay measures measurement measuring thiols L-cysteines L-glutathiones residues proteins antioxidants cells cellular lipids nucleic acids peroxidative damages free radicals GSH humans plasmas livers tissues reductases oxidative stress oxidized toxicity nucleophiles amino acids peptides chains serums homogenates lysates urine fluorometric detectors fluorescence fluorescent | ||||
| 10007892 | Thioredoxin Reductase Assay Kit | - |
|
2006-08-31 | 312.503251775848 | thioredoxin-reductase-assay-kit | TrxR Assay Kit | TrxR reductases oxidative stress injury assays kits measures mammalian aurothiomalate DTNB reduction | |||
| 70450 | TMB (hydrochloride hydrate) | 207738-08-7 | >98% |
|
2.491298342541 | tmb-hydrochloride-hydrate | oxidation heme peroxidases hydroperoxides 2HCl diamines cyclooxygenase dihydrochloride dihydrate 64285-73-0 | ||||
| 70455 | TMPD (hydrochloride) | 637-01-4 | >95% |
|
2.204613259668 | tmpd-hydrochloride | Wurster's Reagent; N,N,N',N'-Tetramethyl-p-Phenylenediamine | oxidation heme peroxidases hydroperoxides polyacrylamides gels cyclooxygenase | |||
| 10004257 |
trans- |
134454-31-2 | >95% |
|
2005-03-16 | 56.029569060773 | trans-4-5-epoxy-2-e-decenal | 3-(3-Pentyloxiranyl)-2E-Propenal | aldehydes odorant peroxidation oxidative injury PUFAs polyunsaturated fatty acids reactive aldehydes tools peroxidative damages stress | ||
| 10004224 |
trans- |
478931-82-7 | ≥98% |
|
✓ | 2009-12-22 | 130.317525822723 | trans-ekode-e-ib | 12,13-epoxy-9-keto-10(trans)-Octadecenoic Acid | oxidative stress linoleic acid peroxidation EKODEs antioxidant response elements AREs neuronal cells NQO1 aldosterone corticosterone adrenal cells calcium stimulated synthesis intercellular | |
| 70675 |
trans- |
501-36-0 | >98% |
|
54.732535911601 | trans-resveratrol | (E)-Resveratrol | selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes | |||
| 13130 |
trans- |
- | ≥99% deuterated product |
|
2009-01-14 | 19.885392265193 | trans-resveratrol-d4 | (E)-Resveratrol-d4 | selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins | ||
| 10188 |
trans- |
22255-22-7 | >98% |
|
2004-03-03 | 12.885489703666 | trans-trismethoxy-resveratrol | (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol | selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy | ||
| 13129 |
trans- |
- | ≥99% deuterated product |
|
2009-02-09 | 12.508468106479 | trans-trismethoxy-resveratrol-d4 | (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 | deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins | ||
| 10011659 | Trolox | 53188-07-1 | ≥98% |
|
2008-12-02 | 339.668715469613 | trolox | 6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid | antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive | ||
| 75860 |
U- |
153190-29-5 | >99% |
|
26.920359116022 | u-74389g | Methylated Tirilazad | antioxidants lipid peroxidation ischemia reperfusion U74389G | |||
| 10010245 |
U- |
137018-55-4 | ≥98% |
|
2008-07-08 | 0E-12 | u-83836e | PNU-83836E | antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 | ||
| 10010895 | Xanthine Oxidase Assay Kit | - |
|
2008-03-13 | 241.437209944751 | xanthine-oxidase-assay-kit | XO Assay Kit; Xanthine Oxidoreductase Assay Kit | assays kits plasma serum tissues homogenates oxidoreductases molybdoflavoenzymes human purine catabolism catalyzing catalyzes hydroxylation hypoxanthine uric acids NADH superoxides reactive oxygen species ROS hydrogen peroxides H2O2 inschemia-reperfusion injury molecular cells death degeneration apoptosis mammalian livers intestines diseases horseradish HRP ADHP fluorescence fluorescent resorufin excitation emission wavelengths special:quarterly specialdiscount:50 specialstart:2007-03-01 specialend:2008-05-31 fluorometric | |||
| 10009992 | Zeaxanthin | 144-68-3 | ≥98% |
|
2009-02-02 | 25.021215469614 | zeaxanthin | Zeaxanthol; Xanthophyll 3; Anchovyxanthin | carotenoid degeneration AMDs luteins diabetes antioxidant oxidative injury injuries VEGFs macula | ||
| 10007705 |
α- |
- | >98% |
|
2006-06-27 | 10.782265193370 | -cehc | vitamin E GTM kidneys a-tocopherol metabolites alpha-tocopherol natriuretic hormones uremia natriuresis .alpha.-tocopherol .alpha.-CEHC alpha-CEHC a-CEHC endocrinology 4072-32-6 | |||
| 10008652 |
(±)- |
7083-09-2 | >98% |
|
2006-10-18 | 8.544925019731 | -cmbhc | vitamin E tocopherals tocotrienols a-CEHC alpha-CEHC .alpha.-CEHC a-tocopherol alpha-tocopherol .alpha.-tocopherol metabolites g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienols HepG2 cells a-CMBHC alpha-CMBHC .alpha.-CMBHC a-CMHHC alpha-CMHHC .alpha.-CMHHC rac rifmpicin CYP3A cytochromes P450s w-oxidation omega-oxidation .omega.-oxidation b-oxidation beta-oxidation .beta.-oxidation | |||
| 10008377 |
α- |
58864-81-6 | >98% |
|
✓ | 2006-10-18 | 14.192541436463 | -tocotrienol | vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 toxicity HT4 cytosolic glutamatec-Src kinases 12-lipoxygenases 12-LOs | ||
| 89630 |
γ- |
178167-75-4 | >98% |
|
✓ | 3.148001841620 | -cehc | γ-Tocopherol Metabolite; GTM; 2,7,8-trimethyl-2-(β-Carboxy-Ethyl)-6-Hydroxychroman | GTM kidneys g-tocopherol metabolites gamma-tocopherol natriuretic hormones uremia natriuresis .gamma.-tocopherol .gamma.-CEHC gamma-CEHC g-CEHC endocrinology | ||
| 10010621 |
γ- |
- |
|
2008-03-21 | 22.744834254144 | -cehc-eia-kit-plasma-and-serum | 2,7,8-trimethyl-2-(β-Carboxy-Ethyl)-6-Hydroxychroman EIA Kit | competitive quantification kits eias enzymes immunoassays gammaCEHC gCEHC gamma-CEHC g-CEHC tocopherol tocotrienols vitamins E g-tocopherols .gamma.-tocopherol gamma-tocopherol lipid soluble antioxidants diets metabolites livers cytochrome p450 CYP450 natriuretic acitvity nitric oxides NO radicals inhibits inhibitions inhibitors COX cyclooxygenases macrophages epithelial cells plasma serums blood cardiovascular diseases prostate cancers assays | |||
| 10008494 |
γ- |
14101-61-2 | >98% |
|
✓ | 2006-10-20 | 13.905709023941 | -tocotrienol | g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans hypertensive hypertension systolic blood pressures NOS nitric oxides synthases vessels malignant sympathoadrenal +SA mouse murine rats mammary epithelial cells | ||
| 10007706 |
δ- |
1221504-67-1 | >95% |
|
2006-06-27 | 4.390870165746 | -cehc | vitamin E GTM kidneys d-tocopherol metabolites delta-tocopherol natriuretic hormones uremia natriuresis .delta.-tocopherol .delta.-CEHC delta-CEHC d-CEHC endocrinology | |||
| 10008513 |
δ- |
25612-59-3 | >98% |
|
2006-10-20 | 18.636372007366 | -tocotrienol | d-Tocotrienol delta-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neurons neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 cytotoxicity inhibits inhibitors inhibition HAECs U937 monocytic cells VCAM-1 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search